Vitality Watch

Dossier clinicaltrials trial early 14-sep-2026
Small or early-phase human trial or pilot study

Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors

Key claim: A clinical trial will test whether lifestyle therapy (diet-induced weight loss plus exercise) combined with metformin is the most effective strategy to reverse sarcopenic obesity and frailty in older obese Veterans.

Abstract

The continuing increase in prevalence of obesity in older adults including many older Veterans has become a major health concern. The clinical trial will test the central hypothesis that a multicomponent intervention consisting of lifestyle therapy (diet-induced weight loss and exercise training) plus metformin will be the most effective strategy for reversing sarcopenic obesity and frailty in older Veterans with obesity.

Why this matters

A clinical trial will test whether lifestyle therapy (diet-induced weight loss plus exercise) combined with metformin is the most effective strategy to reverse sarcopenic obesity and frailty in older obese Veterans.

Source

Link

Briefing card

Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors
Stage: trial early · clinicaltrials · 14-sep-2026

A clinical trial will test whether lifestyle therapy (diet-induced weight loss plus exercise) combined with metformin is the most effective strategy to reverse sarcopenic obesity and frailty in older obese Veterans.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT04221750

build build 880 · 2bcef25 · 2026-11-18